FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1237358001: Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug)


Status: current, Defined. Date: 31-Aug 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5097894011 Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
5097895012 Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Is a Levocetirizine and montelukast only product in oral dose form true Inferred relationship Some
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Has manufactured dose form Tablet for oral suspension true Inferred relationship Some
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Has unit of presentation Tablet true Inferred relationship Some
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Has precise active ingredient Montelukast sodium true Inferred relationship Some 1
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Has BoSS Montelukast true Inferred relationship Some 1
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Has presentation strength numerator unit mg true Inferred relationship Some 1
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Has precise active ingredient Levocetirizine dihydrochloride true Inferred relationship Some 2
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Has BoSS Levocetirizine dihydrochloride true Inferred relationship Some 2
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Has presentation strength numerator unit mg true Inferred relationship Some 2
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension Has presentation strength denominator unit Tablet true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start